DAYSHA CROSIER: Open Payments
NPI 1942993837 · PRINEVILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $154 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $181 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| PFIZER INC. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: Ozempic, GEMTESA, Wegovy, PREVNAR 20, REXULTI, MOUNJARO, XIFAXAN, VOQUEZNA.
Industry payments across OR — which companies pay providers there.
